Healthcare provider profile · identity verified

David Gray, MD

Family Practice · BURNSVILLE, MN · NPI 1053312256

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	491	142
Amlodipine Besylate	Amlodipine Besylate	360	109
Losartan Potassium	Losartan Potassium	333	98
Lisinopril	Lisinopril	255	84
Simvastatin	Simvastatin	232	62
Levothyroxine Sodium	Levothyroxine Sodium	193	53
Omeprazole	Omeprazole	188	61
Metoprolol Succinate	Metoprolol Succinate	177	57
Tamsulosin Hcl	Tamsulosin Hcl	139	43
Trazodone Hcl	Trazodone Hcl	133	37
Hydrochlorothiazide	Hydrochlorothiazide	130	41
Metformin Hcl Er	Metformin Hcl	125	45
Gabapentin	Gabapentin	123	32
Allopurinol	Allopurinol	93	25
Rosuvastatin Calcium	Rosuvastatin Calcium	93	32
Metformin Hcl	Metformin Hcl	78	25
Sertraline Hcl	Sertraline Hcl	76	24
Finasteride	Finasteride	69	25
Pravastatin Sodium	Pravastatin Sodium	69	19
Furosemide	Furosemide	64	24
Citalopram Hbr	Citalopram Hydrobromide	63	18
Duloxetine Hcl	Duloxetine Hcl	59	13
Carvedilol	Carvedilol	55	17
Metoprolol Tartrate	Metoprolol Tartrate	50	16
Pantoprazole Sodium	Pantoprazole Sodium	50	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	15
Eliquis	Apixaban	47	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	suppressed
Famotidine	Famotidine	45	15
Potassium Chloride	Potassium Chloride	40	13
Atenolol	Atenolol	39	11
Fluticasone Propionate	Fluticasone Propionate	39	18
Albuterol Sulfate Hfa	Albuterol Sulfate	37	25
Jardiance	Empagliflozin	37	suppressed
Prednisone	Prednisone	37	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Glipizide Er	Glipizide	36	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	12
Escitalopram Oxalate	Escitalopram Oxalate	34	11
Fluoxetine Hcl	Fluoxetine Hcl	33	11
Spironolactone	Spironolactone	33	suppressed
Xarelto	Rivaroxaban	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Azelastine Hcl	Azelastine Hcl	28	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Donepezil Hcl	Donepezil Hcl	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	11
Acyclovir	Acyclovir	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Valsartan	Valsartan	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Glipizide	Glipizide	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Ozempic	Semaglutide	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Baclofen	Baclofen	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error